346 related articles for article (PubMed ID: 30536464)
41. Phaeochromocytoma, new genes and screening strategies.
Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
[TBL] [Abstract][Full Text] [Related]
42. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?
Jiménez C; Cote G; Arnold A; Gagel RF
J Clin Endocrinol Metab; 2006 Aug; 91(8):2851-8. PubMed ID: 16735498
[TBL] [Abstract][Full Text] [Related]
43. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
[TBL] [Abstract][Full Text] [Related]
44. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
[TBL] [Abstract][Full Text] [Related]
45. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
Vermalle M; Tabarin A; Castinetti F
Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
[TBL] [Abstract][Full Text] [Related]
46. Identification of a TMEM127 variant in a patient with paraganglioma and acromegaly.
Stütz B; Korbonits M; Kothbauer K; Müller W; Fischli S
Endocrinol Diabetes Metab Case Rep; 2020 Sep; 2020():. PubMed ID: 33416299
[TBL] [Abstract][Full Text] [Related]
47. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
Kuo MJM; Nazari MA; Jha A; Pacak K
Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
[TBL] [Abstract][Full Text] [Related]
48. Pheochromocytoma: When to search a germline defect?
Buffet A; Burnichon N; Amar L; Gimenez-Roqueplo AP
Presse Med; 2018; 47(7-8 Pt 2):e109-e118. PubMed ID: 30100270
[TBL] [Abstract][Full Text] [Related]
49. The genetic basis of pheochromocytoma.
Gimm O; Koch CA; Januszewicz A; Opocher G; Neumann HP
Front Horm Res; 2004; 31():45-60. PubMed ID: 14674304
[TBL] [Abstract][Full Text] [Related]
50. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.
Erlic Z; Rybicki L; Peczkowska M; Golcher H; Kann PH; Brauckhoff M; Müssig K; Muresan M; Schäffler A; Reisch N; Schott M; Fassnacht M; Opocher G; Klose S; Fottner C; Forrer F; Plöckinger U; Petersenn S; Zabolotny D; Kollukch O; Yaremchuk S; Januszewicz A; Walz MK; Eng C; Neumann HP;
Clin Cancer Res; 2009 Oct; 15(20):6378-85. PubMed ID: 19825962
[TBL] [Abstract][Full Text] [Related]
51. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
52. Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome.
Greenberg SE; Jacobs MF; Wachtel H; Anson A; Buchmann L; Cohen DL; Bonanni M; Bennett B; Naumer A; Schaefer AM; Kohlmann W; Nathanson KL; Else T; Fishbein L
Genet Med; 2020 Dec; 22(12):2101-2107. PubMed ID: 32741965
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
Lalloo F
Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
[TBL] [Abstract][Full Text] [Related]
54. Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
Flynn A; Dwight T; Harris J; Benn D; Zhou L; Hogg A; Catchpoole D; James P; Duncan EL; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
J Clin Endocrinol Metab; 2016 Mar; 101(3):1034-43. PubMed ID: 26796762
[TBL] [Abstract][Full Text] [Related]
55. Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine.
Casey R; Neumann HPH; Maher ER
Hum Mol Genet; 2020 Oct; 29(R2):R128-R137. PubMed ID: 33059362
[TBL] [Abstract][Full Text] [Related]
56. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era.
Pillai S; Gopalan V; Smith RA; Lam AK
Crit Rev Oncol Hematol; 2016 Apr; 100():190-208. PubMed ID: 26839173
[TBL] [Abstract][Full Text] [Related]
57. Pathology and genetics of phaeochromocytoma and paraganglioma.
Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ
Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044
[TBL] [Abstract][Full Text] [Related]
58. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
[TBL] [Abstract][Full Text] [Related]
59. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.
Galan SR; Kann PH
Clin Endocrinol (Oxf); 2013 Feb; 78(2):165-75. PubMed ID: 23061808
[TBL] [Abstract][Full Text] [Related]
60. Pheochromocytoma: the expanding genetic differential diagnosis.
Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]